IRIS - Res&Arch Institutional Research Information System - Research & Archive

CECCHETTI, Violetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.281
AS - Asia 5.922
EU - Europa 5.864
SA - Sud America 809
Continente sconosciuto - Info sul continente non disponibili 601
AF - Africa 156
OC - Oceania 15
Totale 22.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.053
SG - Singapore 2.530
IT - Italia 1.100
CN - Cina 903
UA - Ucraina 901
IE - Irlanda 870
VN - Vietnam 779
HK - Hong Kong 737
RU - Federazione Russa 736
SE - Svezia 659
BR - Brasile 613
DE - Germania 365
FI - Finlandia 270
FR - Francia 265
GB - Regno Unito 210
KR - Corea 197
IN - India 124
CA - Canada 114
BE - Belgio 113
TR - Turchia 111
BD - Bangladesh 91
JP - Giappone 83
PL - Polonia 73
MX - Messico 64
AR - Argentina 61
IQ - Iraq 54
NL - Olanda 49
RO - Romania 45
UZ - Uzbekistan 45
ZA - Sudafrica 45
PK - Pakistan 39
CH - Svizzera 38
SA - Arabia Saudita 37
ES - Italia 35
ID - Indonesia 35
EC - Ecuador 33
AT - Austria 29
CO - Colombia 28
PH - Filippine 27
CZ - Repubblica Ceca 26
VE - Venezuela 24
EG - Egitto 20
MA - Marocco 18
CL - Cile 16
LB - Libano 14
AU - Australia 13
CI - Costa d'Avorio 13
ET - Etiopia 13
MY - Malesia 13
AE - Emirati Arabi Uniti 12
KE - Kenya 12
CR - Costa Rica 11
IL - Israele 11
JO - Giordania 10
LT - Lituania 10
UY - Uruguay 10
BG - Bulgaria 9
TN - Tunisia 9
DZ - Algeria 8
GR - Grecia 8
KG - Kirghizistan 8
PY - Paraguay 8
DK - Danimarca 7
EE - Estonia 7
EU - Europa 7
IR - Iran 7
LV - Lettonia 7
NP - Nepal 7
PE - Perù 7
AL - Albania 6
BO - Bolivia 6
PA - Panama 6
HN - Honduras 5
JM - Giamaica 5
OM - Oman 5
RS - Serbia 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
AM - Armenia 4
AZ - Azerbaigian 4
KZ - Kazakistan 4
PR - Porto Rico 4
PS - Palestinian Territory 4
PT - Portogallo 4
SV - El Salvador 4
AO - Angola 3
BY - Bielorussia 3
GT - Guatemala 3
HR - Croazia 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
LY - Libia 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
Totale 22.019
Salva come PNG Salva come JPEG
Città #
Singapore 1.848
Chandler 1.091
San Jose 890
Dublin 870
Hong Kong 720
Ashburn 673
Dong Ket 487
Jacksonville 484
Perugia 469
San Mateo 460
Santa Clara 338
Boardman 307
Council Bluffs 292
Beijing 222
Moscow 206
Medford 205
Princeton 205
Seoul 193
Lauterbourg 178
Ann Arbor 167
Los Angeles 163
Wilmington 159
Altamura 146
Andover 128
New York 127
The Dalles 125
Lawrence 123
Brussels 113
Ho Chi Minh City 109
Munich 99
Piscataway 83
Fremont 77
Tokyo 75
Des Moines 68
São Paulo 64
Dallas 62
Hanoi 61
Saint Petersburg 57
Turku 54
Orem 53
Warsaw 48
West Jordan 48
Izmir 45
Atlanta 44
Nanjing 43
Redmond 43
Montreal 40
Norwalk 39
Denver 38
Rome 38
Dearborn 36
Brooklyn 35
Chicago 35
Helsinki 35
Phoenix 35
Woodbridge 35
Buffalo 28
Falls Church 28
Baghdad 26
Columbus 26
Bucharest 25
Poplar 25
Spoleto 25
Chennai 24
Hefei 24
Houston 24
Johannesburg 24
Shanghai 24
San Giustino 23
Tashkent 23
Washington 23
London 22
San Francisco 22
San Paolo di Civitate 22
Mexico City 21
Philadelphia 21
Redwood City 21
Seattle 21
Stockholm 21
Dhaka 20
San Diego 20
Rio de Janeiro 18
Ankara 17
Charlotte 17
Boston 16
Den Haag 16
Mumbai 16
Milan 15
Secaucus 15
Toronto 15
Auburn Hills 14
Chongqing 14
Da Nang 14
Manchester 14
Abidjan 13
Bologna 13
Brasília 13
Curitiba 13
Hanover 13
Olomouc 13
Totale 13.750
Salva come PNG Salva come JPEG
Nome #
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 350
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 343
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 326
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 325
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 256
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 214
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 192
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 171
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 167
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 166
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 159
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 158
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 156
New Insights on KCa3.1 Channel Modulation 155
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 152
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 151
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 151
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 149
Attivatori dei canali KATP a struttura 1,4-benzotiazinica. Modificazioni in N-4 148
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 147
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 147
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 145
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 145
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 144
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 144
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 143
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 143
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 142
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 140
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 139
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 138
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 138
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 137
6-Aminoquinolones as New Potential Anti-HIV Agents 135
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 133
A Comprehensive Structural Overview of p38 Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders 133
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 133
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 132
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 131
6-Desfluoroquinolones as promising HIV transcription inhibitors 131
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 130
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 130
S. aureus NorA efflux pump: the discovery of new potent inhibitors 129
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 128
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 127
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 127
Process for the Preparation of 9-Fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic Acid Hydrochloride 126
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 125
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 124
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 123
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 123
Chemometric rationalization of the structural features affecting the antibacterial activity of quinolones 122
Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents 121
Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38α MAPK inhibitors 121
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 121
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 120
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 120
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 120
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 120
Enantiomers of 8-(3-tert-Butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H-(1,4)benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity. 120
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 119
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 118
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 118
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 116
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 116
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 115
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 115
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 115
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 114
New Heterocyclic Ring Systems. XIII.7,11-Dithiaazasteroid Analogues 113
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 113
A New Derivative with Ultra-Potent Anti-HIV Activity 113
A new 6-aminoquinolone compound with anti-HCMV activity 113
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 113
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 113
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 113
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 112
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 112
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 112
The antibacterial activity of quinolones against E.coli: a chemometric study 111
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 111
QSAR study and VolSurf characterization of anti-HIV quinolone library 110
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 110
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 110
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 110
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 108
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 108
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 107
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 107
Chemometric Rationalization of the Structural Features Affecting the Antibacterial Activity of Quinolones Against Staphylococcus aureus 106
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 106
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 105
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 105
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 103
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 103
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 102
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 101
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 101
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 101
6-Aminoquinolones targeting HCV NS5B polymerase. 101
Totale 13.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.895
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.895
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.567 0 0 0 129 145 17 48 570 88 58 241 271
2022/20233.237 227 527 49 304 282 338 3 164 1.156 24 119 44
2023/20241.396 83 192 68 32 24 39 292 34 171 93 169 199
2024/20253.412 51 287 122 298 403 167 288 193 590 198 543 272
2025/20266.868 494 451 336 883 917 665 1.153 367 738 568 221 75
2026/20271.440 135 191 356 758 0 0 0 0 0 0 0 0
Totale 22.648